Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease (Q33927688)

30 July 2017

title

Genome wide association (GWA) predictors of anti-TNFalpha therapeutic responsiveness in pediatric inflammatory bowel disease (English)

1 reference

genome-wide association study

30 July 2017

main subject

0 references

inflammatory bowel diseases

0 references

0 references

5

Talin Haritunians

1 reference

30 July 2017

12

Jerome I Rotter

1 reference

30 July 2017

6

Hakon Hakonarson

1 reference

30 July 2017

10

Dermot P McGovern

1 reference

30 July 2017

11

Kent D Taylor

1 reference

30 July 2017

9

Stephan R Targan

1 reference

30 July 2017

Joseph Glessner

8

1 reference

ORCID Public Data File 2021

author name string

Marla C Dubinsky

1

1 reference

30 July 2017

Ling Mei

2

1 reference

30 July 2017

Madison Friedman

3

1 reference

30 July 2017

Tanvi Dhere

4

1 reference

30 July 2017

Cecilia Kim

7

1 reference

30 July 2017

publication date

1 August 2010

1 reference

Inflammatory Bowel Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

1357-1366

1 reference

A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

SLCO1B1 variants and statin-induced myopathy--a genomewide study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Increased immune reactivity predicts aggressive complicating Crohn's disease in children

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

PLINK: a tool set for whole-genome association and population-based linkage analyses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Principal components analysis corrects for stratification in genome-wide association studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Infliximab for induction and maintenance therapy for ulcerative colitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

A simple index of Crohn's-disease activity

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease

5 July 2018

1 reference

Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.

21 January 2018

1 reference

ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease

21 January 2018

1 reference

Predictors of early response to infliximab in patients with ulcerative colitis

21 January 2018

1 reference

A genome-wide scalable SNP genotyping assay using microarray technology

21 January 2018

1 reference

Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2889173

Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

29 October 2018

1 reference

Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab

21 January 2018

1 reference

NOD2/CARD15 does not influence response to infliximab in Crohn's disease

21 January 2018

1 reference

Predictors of Crohn's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20014019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Maintenance therapy with certolizumab pegol for Crohn's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20014019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with -308 TNF gene polymorphism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20014019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/IBD.21174

1 reference

30 July 2017

1 reference

30 July 2017

1 reference